DanStem – University of Copenhagen

News and Events

  • World diabetes Day 2017: Raising Awareness and Hope

    2017.11.14

    415 million people worldwide have been diagnosed with diabetes and the number continues to rise. Common to all diabetes patients is lacking the ability to produce sufficient amounts of insulin, which regulates the blood sugar in the body. This can lead to a number of complications and in many cases be potentially fatal.  »

  • DanStem Seminar by Hitoshi Niwa, 13 November 2017, 12:15

    2017.11.06

    Hitoshi Niwa, Institute of Molecular Embryology and Genetics, (IMEG), Japan
    Talk title: The role of Klf family members to maintain self-renewal of mouse ES cells »

  • Surprised organ researchers: some cells remain single – others create families

    2017.10.30

    In the future, artificial organs can be created to replace a damaged organ or to produce vital hormones in a laboratory. Researchers do not yet understand how organs develop from a few stem cells into complete organs of many types. New research published in Nature Communications shows surprisingly that some cells generate daughter cells while half remain single. »

  • Stem Cells Pave the Way for new treatment of diabetes

    2017.10.30

    A new stem cell study conducted at the University of Copenhagen shows how we may increase the vital production of insulin in patients suffering from diabetes. The discovery helps to more efficiently at less cost make insulin-producing beta cells from human stem cells. Therefore, the research paves the way for more effective treatment of diabetes. The method may also prove significant to the treatment of a series of other diseases.  »

  • Regulation of cell polarity by EGF signaling controls both organ architecture and cell fate

    2017.10.23

    Scientists at DanStem discovered that cells’ sense of direction (cell polarity) determines their destiny. By discovering the signals that control cell polarity in the developing organism, scientists can now mimic it in a test tube and control the fate of human stem cells. The results accelerate the efforts to generate specialized cells, e.g. insulin-producing beta cells, from stem cells to treat and maybe even cure chronic diseases »

Read all